Written question asked by Lord Austin of Dudley (Labour) on Monday, 11 December 2017, in the House of Commons. It was due for an answer on Wednesday, 13 December 2017. It was answered by Steve Brine (Conservative) on Tuesday, 19 December 2017 on behalf of the Department of Health.
Cystic Fibrosis
- Question
-
To ask the Secretary of State for Health, what assessment he has made of the effect of the implementation of the recommendations from the Accelerated Access Review on people with cystic fibrosis; and what the timetable is for the implementation of those recommendations.
- Answer
-
The Government and partners published the response to the Accelerated Access Review on 3 November which outlines plans for implementation. Since the Accelerated Access Collaborative has not yet selected any products, we have not made any assessment of the effect of implementation on any particular condition. The Accelerated Access Pathway will be operational from April 2018 when it will begin selecting products.
Secondary information
- Type
- Written question
- Reference
- 118693
- Session
- 2017-19
- Subjects
- Cystic fibrosis Drugs NHS Medical treatments
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2017-12-19 20:07:18 +0000
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2017-19/118693
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2017-19/118693
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2017-19/118693